A Phase 2 Trial of MLN8237 in Adult Patients With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Millennium Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier:

NCT00830518

First received: January 27, 2009

Last updated: January 26, 2012

Last verified: January 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	January 26, 2012